- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Survey of Hospital Pharmacists' Opinions of Current Japanese Package Inserts
-
- Saito Mitsuo
- Division of Medicinal Safety Science, National Institute of Health Sciences
-
- Hirata Mutsuko
- Division of Medicinal Safety Science, National Institute of Health Sciences
-
- Urano Tsutomu
- Division of Medicinal Safety Science, National Institute of Health Sciences
-
- Miyake Shinji
- Division of Medicinal Safety Science, National Institute of Health Sciences
-
- Hasegawa Ryuichi
- Division of Medicinal Safety Science, National Institute of Health Sciences
Bibliographic Information
- Other Title
-
- 現行の添付文書に対する病院薬剤師の意識調査
Search this article
Description
The package insert (PI) is a primary source of information for healthcare providers and their format in Japan was dramatically altered in 1997 to make them simpler and easier to understand.In order to investigate the attitude of hospital pharmacists toward current Japanese PIs and how they are used,we sent a questionnaire to 320 hospitals in cooperation with the Japanese Society of Hospital Pharmacists.It had a general section and a more detailed section that focused on drug interactions and pharmacokinetics.<br>We received responses from 266 hospitals (83.1%).The majority of respondents approved of the order of the current PI (94.2%) and all of them felt the need for background information when the details of a PI were revised.In the section of the questionnaire on drug interactions and pharmacokinetics,nearly all of the respondents approved the tabulation of drug interactions (99.2%).On the other hand,many responders considered detailed information such as that concerning drug names,quantitative pharmacokinetic data and specific metabolic enzymes to be insufficient,and many wanted to have note made when a pharmacokinetic effect was observed in healthy volunteers (67.7%).A large number of pharmacists also wished to have more information on drug interactions.<br>In conclusion,we feel that a minimal amount of quantitative data on drug interactions and other critical information needs to be included in PIs without spoiling the current easy-to-understand format.
Journal
-
- Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
-
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 33 (5), 442-450, 2007
Japanese Society of Pharmaceutical Health Care and Sciences
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679752354304
-
- NII Article ID
- 110006273478
-
- NII Book ID
- AA11527197
-
- ISSN
- 18821499
- 1346342X
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- NDL Digital Collections (NII-ELS)
- CiNii Articles
-
- Abstract License Flag
- Disallowed